The Trademark Trial and Appeal Board has scheduled six (VI) oral hearings for the month of March, as listed below. Four of the hearings will be held in the East ...
Prospective amici in support of petitioner in Sequenom, Inc. v. Ariosa Diagnostics, Inc., Supreme Court No. 15A871, would do well to defer a final decision whether to join this case as ...
Today in the Humira® case, Fujifilm Kyowa Biologics Co., Ltd. v. Abbvie Biotechnology Limited, [2016] EWHC 374(IP)(Ch)(High Court 2016)(Carr, J.), the trial court issued an opinion involving parallel proceedings within ...
Whither Patent “Evergreening”, the Spangenberg Critique Erich Spangenberg has authored an attack on the current Administration and its Under Secretary in charge of the patent system [FNa]. His focus is ...
Responsive to the previous note (reproduced below) an astute observer points to the limited scope of post-grant review in a controversial Patent Office decision. The observer cites a PTAB decision ...
Although consent agreements are frequently entitled to great weight in its likelihood of confusion analysis, the Board was unmoved by a consent agreement in its affirmance of a Section 2(d) ...
Top Ten No. (1) Sequenom v. Ariosa: From the standpoint of the law of patent-eligibility under 35 USC §101, this is a most important case. The petition is now due ...
Further to the note earlier today (attached below), this morning the Court denied petitions for certiorari in ePlus and Arthrex. TopTenCases2016Feb29 Regards Hal
In Samsung v. Apple, the Supreme Court is scheduled to vote this Friday whether to grant certiorari in a design patent infringement case where the first Question Presented asks: “Where ...
As the April 1st certiorari deadline approaches in Sequenom, Inc. v. Ariosa Diagnostics, Inc., Supreme Court No. 15A871, the underlying facts seemingly compel industry amici support to make sure that the ...